Efficacy and Safety of Risedronate in Osteoporosis Subjects with Comorbid Diabetes, Hypertension, and/or Dyslipidemia: A Post Hoc Analysis of Phase III Trials Conducted in Japan
Crossref DOI link: https://doi.org/10.1007/s00223-015-0071-9
Published Online: 2015-10-14
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Inoue, Daisuke
Muraoka, Ryoichi
Okazaki, Ryo
Nishizawa, Yoshiki
Sugimoto, Toshitsugu
License valid from 2015-10-14